| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Hemp, Inc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.000001 |
| 52 Week High | US$0.0003 |
| 52 Week Low | US$0.000001 |
| Beta | 4.82 |
| 1 Month Change | -99.00% |
| 3 Month Change | -99.00% |
| 1 Year Change | -99.60% |
| 3 Year Change | -99.99% |
| 5 Year Change | -100.00% |
| Change since IPO | -99.99% |
Recent News & Updates
Recent updates
Shareholder Returns
| HEMP | US Chemicals | US Market | |
|---|---|---|---|
| 7D | 0% | -3.1% | -3.7% |
| 1Y | -99.6% | 5.4% | 20.5% |
Return vs Industry: HEMP underperformed the US Chemicals industry which returned 5.4% over the past year.
Return vs Market: HEMP underperformed the US Market which returned 20.5% over the past year.
Price Volatility
| HEMP volatility | |
|---|---|
| HEMP Average Weekly Movement | 5,753.7% |
| Chemicals Industry Average Movement | 5.5% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.4% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: HEMP's share price has been volatile over the past 3 months.
Volatility Over Time: HEMP's weekly volatility has increased from 5559% to 5800% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2008 | n/a | Gary Perlowin | www.hempinc.com |
Hemp, Inc. provides industrial hemp in the United States. The company offers pre-roll blends, fortified pre-rolls; Bubba Kush hemp; caviar/moon rocks; and diamonds and crumbles. It is also involved in the processing and farming industrial hemp; extracting hemp CBD oil; and provides education seminar for farmers and entrepreneurs, as well as provides research and development, and hemp consulting.
Hemp, Inc Fundamentals Summary
| HEMP fundamental statistics | |
|---|---|
| Market cap | US$40.02k |
| Earnings (TTM) | -US$5.48m |
| Revenue (TTM) | US$184.40k |
0.2x
P/S Ratio0.0x
P/E RatioIs HEMP overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HEMP income statement (TTM) | |
|---|---|
| Revenue | US$184.40k |
| Cost of Revenue | US$96.55k |
| Gross Profit | US$87.84k |
| Other Expenses | US$5.57m |
| Earnings | -US$5.48m |
Last Reported Earnings
Dec 31, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.00014 |
| Gross Margin | 47.64% |
| Net Profit Margin | -2,973.03% |
| Debt/Equity Ratio | 234.3% |
How did HEMP perform over the long term?
See historical performance and comparison